LV12888B - 3-(pie slāpekļa atoma aizvietoti)fenil-5-beta-amidometiloksazolidin-2-oni - Google Patents
3-(pie slāpekļa atoma aizvietoti)fenil-5-beta-amidometiloksazolidin-2-oni Download PDFInfo
- Publication number
- LV12888B LV12888B LVP-02-104A LV020104A LV12888B LV 12888 B LV12888 B LV 12888B LV 020104 A LV020104 A LV 020104A LV 12888 B LV12888 B LV 12888B
- Authority
- LV
- Latvia
- Prior art keywords
- alkyl
- defined above
- optionally substituted
- oxazolidin
- taken together
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Claims (6)
- LV 12888 IZGUDROJUMA FORMULA 3-(Pie slāpekļa atoma aizvietots)fenil-53-(amidometil)oksazolidin-2-ons ar formulu (LV)4 kur (I) Rļ ir-H, Cļ-C^alkilgrupa, kas neobligāti ir aizvietota ar 1-3 Cl atomiem, C3-C12cikloalkilgrupa, C5-C12alkenilgrupa, kas satur vienu dubultsaiti, -<ļ>, kas neobligāti ir aizvietots ar 1-3 grupām, kas ir izvēlētas no-N(R1.1)(R1.2), kur R,.! un R1.2 ir vienādi vai atšķirīgi un ir -H vai Cļ-C^alkilgrupa, furanilgrupa, tetrah id rof u ran i Ig ru pa, 2-tiofēngrupa, pirolidinilgrupa, piridinilgrupa, -0-R,.3, kur R1-3 ir Cļ-C^alkilgrupa, -NHRļ.3, kur R^ ir, kā noteikts iepriekš, -NR^R^, kur R1-4 ir C1-C3alkilgrupa un R^ ir, kā noteikts iepriekš, un kur R,.3 un R,.4 var tikt ņemti kopā ar pievienoto slāpekļa atomu, lai veidotu piesātinātu C5-C7 heterociklisku gredzenu ar vienu slāpekļa atomu, kas ietver -0-, -CH2-OH, 2 -CHpRļ.g, kur R,_5 ir Cļ-C^alkilgrupa vai -CO-Rļ.g, kur R^ ir CrC4alkilgrupa vai -φ; (II) divi no R2, R3 un R4 ir -H un citi no R2, R3 un R4 ir -H, 5 -F, -Cl, -Br, -I, Cļ-Cgalkilgrupa, -OH, -CO-O-R^, kur R^ ir CrC4alkilgrupa vai -φ, 10 -O-R^, kur R2_i ir, kā noteikts iepriekš, -COOH, -COO, -CHO, -CO-NR2.2R2.3, kur R2.2 un R2.3 ir vienādi vai atšķirīgi un ir -H, 15 Cļ-C^alkilgrupa vai R2.2 un R2.3 ir ņemti kopā ar pievienoto slāpekļa atomu, lai veidotu piesātinātu C3-C6heterociklisku gredzenu ar vienu slāpekļa atomu, kas neobligāti satur -0-, -C=N, -OCH, 20 -N=C, -CHOH-CH3, -CO-CH3, -SH, -SO-CH3,
- 25 -SO-φ, -s-ch3, -S-φ, -S02-CH3, -302-φ, 30 -S03H, -so2-nh2, -n3, -no2, 3 LV 12888 -NR2.4R2.5, kur R2.4 un R2.5 ir vienādi vai atšķirīgi un ir -H un Cļ-Caalkilgrupa, -NH-CO-R2.6, kur R2.6 ir Cļ-C^alkilgrupa vai -φ, -NH-CO-NH2, -ch=ch2, -ch2-ch=ch2, -CH=N-OH, -CH=N-OCH3, -ch3-c=n-oh, I -CH3-C=N-OCH3i I -C*H-CH2-0*, kur atomi, kas ir iezīmēti ar zvaigznīti (*), ir piesaistīti viens otram, rezultātā veidojot ciklu, (INA) kur W, un W2 ņemti kopā ir (XXXII), -nr5-n=cr6- kur R5 ir C^Cļgalkilgrupa, -ΟΗ2-φ, -ΟΗ2ΟΗ2-φ, C3-C7cikloalkilgrupa, C2-C12alkenilgrupa, kas satur no 1 līdz 3 dubultsaitēm ieskaitot, C2-C12alkinilgrupa, kas satur 1 trīskāršo saiti, -CHO, -CO-R^, kur R^ ir (A) CrC6alkilgrupa, kas neobligāti ir aizvietota ar 1 -0-CH3, -COOH, -NH2, -S03H vai 1-3 -Cl, (B) C3-C7cikloalkilgrupa, (C) 2-piridinilgrupa, 2-tiofēngrupa, 2-tiofēnmetilgrupa vai 2-pirolgrupa, 4 (D) -<ļ>, kas neobligāti ir aizvietots ar 1-3 -F, -Cl, -Br, -I, CVCgalkilgrupām, -OH, -C0-0-R5.2, kur R5.2 ir C^C^Ikilgrupa vai -φ, -0-R5.2, kur R5_2 ir, kā noteikts iepriekš, -COOH, -CO-NR5.3R5.4, kur R5_3 un R5_4 ir vienādi vai atšķirīgi un ir -H, C1-C3alkilgrupa, vai R5_3 un R5.4 ir ņemti kopā ar pievienoto slāpekļa atomu, lai veidotu piesātinātu C3-C6heterociklisku gredzenu ar vienu slāpekļa atomu, kas neobligāti satur -O-, -C=N, -CHOH-CH3, -CO-CH3, -SH, -SO-CH3, -SO-φ, -s-ch3, -S-Φ, -S02-CH3, -302-φ, -so3h, -so2-nh2, -n3, -no2, -NRs_5R5.6, kur R5.5 un R5.6 ir vienādi vai atšķirīgi un ir -H un Cļ-Cgalkilgrupa, -NH-CO-R5.7, kur R5.7 ir CrC4alkilgrupa vai -φ, -C0-0-R5.8, kur R5.8 ir C1-C4alkilgrupa vai -φ, katrs neobligāti ir aizvietots ar 1 vai 2 5 LV 12888 -F, -Cl, -Br, -I, Cļ-Cgalkilgrupām, -OH, -C0-0-R5.2, kur R5.2 ir, kā noteikts iepriekš, -0-R5.2, kur R5.2 ir, kā noteikts iepriekš, -COOH, -CO-NR5.3R5_4, kur R5.3 un R5.4 ir, kā noteikts iepriekš, -CsN, -CHOH-CHj, -CO-CH3, -SH, -SO-CH3, -SO-φ, -S-CH3, -S-φ, -S02-CH3, -802-φ, -so3h, -so2-nh2, -n3, -no2, -NR5.5Rs.6, kur R5.5 un R5.6 ir, kā noteikts iepriekš, -NH-CO-R5.7, kur R5.7 ir, kā noteikts iepriekš, -CO-N(R5.9)2, kur R5.9 ir -H vai R5.8, kā noteikts iepriekš, un kur R5.9 atlikumi var tikt ņemti kopā ar pievienoto slāpekļa atomu, lai veidotu piesātinātu C3-C6heterociklisku gredzenu ar vienu slāpekļa atomu, kas neobligāti satur -0- vai -NH-, -CO-CH2-CN, -co-ch2-oh, -00-ΟΗ2-0-φ, ku^ neobligāti ir aizvietots ar 1-3 -0-CH3, 1 -N02 un 1 -NH2, -CO-CH2-O-R5.10, kur R5.10 ir CrC6alkilgrupa, 6 -φ, kas neobligāti ir aizvietots ar 1 -3 -0-CH3, 1 -N02 un -NHZ, -CO-Rg.^, kur Rg.^ ir Cv-Cgalkilgrupa, -φ, kas neobligāti ir aizvietots ar 1-4 -F, 1-3 -Cl, 1 -OCH3, -OH, -NH2, -N02, -CO-CH3, -S02-CH3 un -S02-0H, -CO-CH(NH-CO-R5.12)-R5.13, kur R5.13 ir -H vai -CR3 un R5.12 ir CrC6alkilgrupa, -φ, kas neobligāti ir aizvietots ar 1 vai 2 -OH, -OCH3, -N02i -NH2i -Cl, -F, -NH-CH3 un -N(CH3)2, -CO-CHNH2-R5.14, kur R5.14 ir -CH(CH3)2, -CH2-CH(CH3)2, -CHCH3-CH2-CH3, -CH2-OH, CH(OH)-CH3, -ΟΗ2-φ, -ΟΗ2-φ-ΟΗ, -CH2-SH, -CH2-CH2-S-CH3 un -CH2-COOH, -S02-CH3, -so2-b, -so3h un R6 ir -H un Cļ-Cgalkilgrupa; vai (IIIB), kur W, un W2 ņemti kopā ir -NR5-N=N- (LIV), kur Rg ir, kā noteikts iepriekš; un tā farmaceitiski pieņemami sāļi. Savienojums saskaņā ar 1. punktu, kur Wļ un W2 ņemti kopā ir -NR5-N=CR6-. Savienojums saskaņā ar 1. punktu, kur Wļ un W2 ņemti kopā ir -NRS-N=N-. Savienojums saskaņā ar jebkuru no iepriekšējiem punktiem, kur R2, R3 un R4 visi ir H. 7 LV 12888
- 5. Savienojums saskaņā ar jebkuru no iepriekšējiem punktiem, kur R, ir H, CrC6alkilgrupa, C3-C6cikloalkilgrupa, -OCH3 vai -CHCĻ un R5 ir izvēlēts no -CH3, -CH2-CH=CH2, -CH2-C=CH, -CHO un -CO-Rg., kur Rs., ir -CH3, -C2H5, -CH(CH3)2, -CHCĻ -CH2OH, -CH2-0-CH3, 2-tiofenilgrupa vai cik-5 lopentilgrupa.
- 6. Savienojums saskaņā ar 2. punktu, kurš ir 3-[5’-(1-acetilindazolil)]-5P-(acetamidometil)oksazolidin-2-ons, 3-(5’-indazolil)^-(acetamidometil)oksazolidin-2-ons, 10 3-[5’-(1 -etilindazolil)]-53-(acetamidometil)oksazolidin-2-ons vai 3-[5’-(1-n-propilindazolil)]-5p-(acetamidometil)oksazolidin-2-ons.
- 7. Savienojuma saskaņā ar jebkuru no iepriekšējiem punktiem izmantošana ārstniecības līdzekļa ražošanai izmantošanai gram-pozitīvu vai anaerobu 15 organismu izraisītu infekciju ārstēšanā.
- 8. Savienojums saskaņā ar jebkuru no 1. punkta līdz 4. punktam, izņemot to, ka Rs ir H.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24498888A | 1988-09-15 | 1988-09-15 | |
US25385088A | 1988-10-05 | 1988-10-05 | |
US32494289A | 1989-03-17 | 1989-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
LV12888B true LV12888B (lv) | 2002-12-20 |
Family
ID=27399816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-02-104A LV12888B (lv) | 1988-09-15 | 2002-06-06 | 3-(pie slāpekļa atoma aizvietoti)fenil-5-beta-amidometiloksazolidin-2-oni |
Country Status (14)
Country | Link |
---|---|
EP (3) | EP0609905B1 (lv) |
JP (2) | JP2865211B2 (lv) |
KR (1) | KR0138262B1 (lv) |
AT (2) | ATE201870T1 (lv) |
AU (1) | AU617871B2 (lv) |
CA (1) | CA1335103C (lv) |
DE (2) | DE68918792T2 (lv) |
DK (2) | DK175696B1 (lv) |
ES (1) | ES2157934T3 (lv) |
GR (1) | GR3036491T3 (lv) |
HK (1) | HK1002234A1 (lv) |
LV (1) | LV12888B (lv) |
TW (1) | TW219936B (lv) |
WO (1) | WO1990002744A1 (lv) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231188A (en) * | 1989-11-17 | 1993-07-27 | The Upjohn Company | Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents |
ATE204275T1 (de) * | 1990-06-07 | 2001-09-15 | Astrazeneca Ab | Indolderivate als 5-ht1-like agonisten |
CZ283323B6 (cs) * | 1991-08-14 | 1998-02-18 | Procter And Gamble Pharmaceuticals, Inc. | Cyklické urethany použitelné jako antiarytmická a antifibrilační činidla a farmaceutické přípravky, které je obsahují |
SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
AU666740B2 (en) * | 1992-07-08 | 1996-02-22 | Upjohn Company, The | 5'-indolinyl oxazolidinones useful against (mycobacterium tuberculosis) |
US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
DE4425609A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Benzofuranyl- und Benzothienyloxazolidinone |
DE4425612A1 (de) * | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
DE4425613A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
DE19514313A1 (de) * | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
CZ291847B6 (cs) * | 1994-10-26 | 2003-06-18 | Pharmacia Upjohn Company | Antimikrobiální fenyloxazolidinony |
RU2128660C1 (ru) * | 1994-11-15 | 1999-04-10 | Фармация Энд Апджон Компани | Бициклические оксазин- или тиазин-оксазолидиноны или их фармацевтически приемлемые соли и способы лечения микробных инфекций |
PL185872B1 (pl) * | 1995-02-03 | 2003-08-29 | Upjohn Co | Nowe podstawione fenylooksazolidynonyNowe podstawione fenylooksazolidynony |
HRP960159A2 (en) * | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
DE69614847T2 (de) * | 1995-05-11 | 2002-04-04 | Pharmacia & Upjohn Co., Kalamazoo | Spirocyclische und bicyclische diazinyl- und carbazinyloxazolidinone |
US5883093A (en) * | 1995-09-12 | 1999-03-16 | Pharmacia & Upjohn Company | Phenyloxazolidinone antimicrobials |
ZA968661B (en) * | 1995-11-17 | 1998-04-14 | Upjohn Co | Oxazolidinone antibacterial agent with tricyclic substituents. |
DE19601265A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
DE19601264A1 (de) * | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
DE19601627A1 (de) | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
GB9601666D0 (en) * | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
HRP970049A2 (en) | 1996-02-06 | 1998-04-30 | Bayer Ag | New heteroaryl oxazolidinones |
DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
GB9702213D0 (en) * | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
GB9609919D0 (en) | 1996-05-11 | 1996-07-17 | Zeneca Ltd | Chemical compounds |
US6255304B1 (en) | 1997-05-30 | 2001-07-03 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
ATE293609T1 (de) | 1997-05-30 | 2005-05-15 | Upjohn Co | Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität |
DE19730847A1 (de) * | 1997-07-18 | 1999-01-28 | Bayer Ag | Tricyclisch substituierte Oxazolidinone |
GB9717804D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
GB9717807D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
EP1030852B1 (en) * | 1997-11-12 | 2003-09-17 | PHARMACIA & UPJOHN COMPANY | Oxazolidinone derivatives and pharmaceutical compositions |
GB9725244D0 (en) | 1997-11-29 | 1998-01-28 | Zeneca Ltd | Chemical compounds |
DE19802239A1 (de) * | 1998-01-22 | 1999-07-29 | Bayer Ag | Neue mit Bicyclen substituierte Oxazolidinone |
US7002020B1 (en) | 1998-01-23 | 2006-02-21 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
NZ505902A (en) * | 1998-01-23 | 2003-08-29 | Upjohn Co | Oxazolidinone compounds useful as antimicrobial agents and combinatorial libraries |
US6562844B2 (en) | 1998-01-23 | 2003-05-13 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
US6387896B1 (en) | 1999-05-27 | 2002-05-14 | Pharmacia & Upjohn Co. | Bicyclic oxazolidinones as antibacterial agents |
AU773359B2 (en) | 1999-07-28 | 2004-05-20 | Pharmacia & Upjohn Company | Oxazolidinones and their use as antiinfectives |
GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
NZ523700A (en) | 2000-07-17 | 2004-11-26 | Ranbaxy Lab Ltd | Oxazolidinone derivatives as antimicrobials |
DE60121986T2 (de) | 2000-10-02 | 2007-07-26 | Emory University | Triptpolidanaloge zur verendung in der behandlung von autoimmunbedingten und entzündlichen erkrankungen |
PE20020689A1 (es) | 2000-11-17 | 2002-08-03 | Upjohn Co | Oxazolidinonas con un heterociclo de 6 o 7 miembros unidos con enlace anular al benceno |
US6956040B2 (en) | 2001-07-16 | 2005-10-18 | Ranbaxy Laboratories Limited | Oxazolidinone piperazinyl derivatives as potential antimicrobials |
GB0118407D0 (en) * | 2001-07-27 | 2001-09-19 | Cipla Ltd | Oxazolidinone derivatives as antibacterial agents |
TW200306819A (en) | 2002-01-25 | 2003-12-01 | Vertex Pharma | Indazole compounds useful as protein kinase inhibitors |
US7012088B2 (en) * | 2003-02-24 | 2006-03-14 | Pharmacia & Upjohn Company | Indolone oxazolidinones and derivatives thereof |
AP2007003904A0 (en) * | 2004-08-06 | 2007-02-28 | Pharmacia & Upjohn Co Llc | Oxazolidinones containing oxindoles as antibacterial agents |
SE0402763D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Nitro indazole derivatives |
WO2006106426A1 (en) * | 2005-04-06 | 2006-10-12 | Pharmacia & Upjohn Company Llc | An oxindole oxazolidinone as antibacterial agent |
AU2006231919A1 (en) | 2005-04-06 | 2006-10-12 | Pharmacia & Upjohn Company Llc | 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
AU2008339607B2 (en) * | 2007-12-24 | 2012-08-02 | Cipla Limited | Process for the synthesis of propargylated aminoindan derivatives |
CA2794153C (en) | 2010-03-25 | 2018-01-02 | Glaxosmithkline Llc | Substituted indoline derivatives as perk inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES533097A0 (es) * | 1983-06-07 | 1985-08-01 | Du Pont | Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno. |
CA1260948A (en) * | 1984-12-05 | 1989-09-26 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents |
US4801600A (en) * | 1987-10-09 | 1989-01-31 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
-
1989
- 1989-08-22 JP JP1509255A patent/JP2865211B2/ja not_active Expired - Fee Related
- 1989-08-22 EP EP94102762A patent/EP0609905B1/en not_active Expired - Lifetime
- 1989-08-22 AT AT94102762T patent/ATE201870T1/de not_active IP Right Cessation
- 1989-08-22 DE DE68918792T patent/DE68918792T2/de not_active Expired - Fee Related
- 1989-08-22 ES ES94102762T patent/ES2157934T3/es not_active Expired - Lifetime
- 1989-08-22 AU AU41957/89A patent/AU617871B2/en not_active Ceased
- 1989-08-22 AT AT89308506T patent/ATE112773T1/de not_active IP Right Cessation
- 1989-08-22 EP EP89308506A patent/EP0359418B1/en not_active Expired - Lifetime
- 1989-08-22 WO PCT/US1989/003548 patent/WO1990002744A1/en not_active Application Discontinuation
- 1989-08-22 DE DE68929303T patent/DE68929303T2/de not_active Expired - Fee Related
- 1989-08-22 EP EP89909990A patent/EP0434714A1/en active Pending
- 1989-08-28 CA CA000609594A patent/CA1335103C/en not_active Expired - Fee Related
- 1989-08-29 TW TW078106662A patent/TW219936B/zh active
-
1990
- 1990-05-15 KR KR1019900701012A patent/KR0138262B1/ko not_active IP Right Cessation
-
1991
- 1991-03-13 DK DK199100455A patent/DK175696B1/da not_active IP Right Cessation
-
1998
- 1998-02-18 HK HK98101252A patent/HK1002234A1/xx not_active IP Right Cessation
- 1998-07-07 JP JP19194998A patent/JP3188418B2/ja not_active Expired - Fee Related
-
2001
- 2001-08-31 GR GR20010401350T patent/GR3036491T3/el not_active IP Right Cessation
-
2002
- 2002-06-06 LV LVP-02-104A patent/LV12888B/lv unknown
-
2004
- 2004-08-18 DK DK200401246A patent/DK175940B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW219936B (lv) | 1994-02-01 |
DE68929303D1 (de) | 2001-07-12 |
JPH1180139A (ja) | 1999-03-26 |
DE68918792T2 (de) | 1995-03-30 |
DK175696B1 (da) | 2005-01-24 |
CA1335103C (en) | 1995-04-04 |
AU617871B2 (en) | 1991-12-05 |
DK45591D0 (da) | 1991-03-13 |
HK1002234A1 (en) | 1998-08-07 |
EP0609905B1 (en) | 2001-06-06 |
JP2865211B2 (ja) | 1999-03-08 |
DK200401246A (da) | 2004-08-18 |
DK175940B1 (da) | 2005-08-01 |
DE68929303T2 (de) | 2002-05-02 |
EP0434714A1 (en) | 1991-07-03 |
ATE112773T1 (de) | 1994-10-15 |
ES2157934T3 (es) | 2001-09-01 |
EP0609905A1 (en) | 1994-08-10 |
DE68918792D1 (de) | 1994-11-17 |
JP3188418B2 (ja) | 2001-07-16 |
EP0359418A1 (en) | 1990-03-21 |
JPH04500665A (ja) | 1992-02-06 |
EP0359418B1 (en) | 1994-10-12 |
KR0138262B1 (ko) | 1998-05-15 |
ATE201870T1 (de) | 2001-06-15 |
AU4195789A (en) | 1990-04-02 |
KR900701780A (ko) | 1990-12-04 |
GR3036491T3 (en) | 2001-11-30 |
WO1990002744A1 (en) | 1990-03-22 |
DK45591A (da) | 1991-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV12888B (lv) | 3-(pie slāpekļa atoma aizvietoti)fenil-5-beta-amidometiloksazolidin-2-oni | |
US5164510A (en) | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones | |
EP1497279B1 (de) | Substituierte indole und deren verwendung als 5ht-wiederaufnahme inhibitoren und als 5ht liganden | |
US5182403A (en) | Substituted 3(5'indazolyl) oxazolidin-2-ones | |
US5225565A (en) | Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones | |
CA2411859A1 (en) | Novel oxazolidinone derivatives and a process for the preparation thereof | |
US11685740B2 (en) | Bicyclic nitrogen-containing heterocyclic derivatives and pharmaceutical composition comprising the same | |
KR20010031953A (ko) | 옥사졸리디논 유도체 및 제약 조성물 | |
WO2017209265A1 (ja) | 二環性複素環誘導体およびそれらを含有する医薬組成物 | |
JP5662940B2 (ja) | 新規な抗微生物薬 | |
JP2019182865A (ja) | 二環性含窒素複素環誘導体を含有する医薬組成物 | |
EP0500686B1 (en) | Tricyclic [6,5,5]/[6,6,5]-fused oxazolidinone antibacterial agents | |
JP2000229978A (ja) | オキサゾリジノン及び抗菌剤としてのそれらの使用 | |
KR101293384B1 (ko) | 신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도 | |
KR20210038632A (ko) | 포유류 감염 치료를 위한 신규 화합물 | |
KR100467309B1 (ko) | 옥사졸리디논유도체및그의제조방법및항균제조성물 | |
AU2021411868A9 (en) | Nrf2-activating compound |